GlaxoSmithKline Accused Of Burying Negative Paxil Studies & Keeping Info From FDA
UPDATED: August 5, 2019
It’s all about you. We want to help you make the right legal decisions.
We strive to help you make confident law decisions. Finding trusted and reliable legal advice should be easy. This doesn't influence our content. Our opinions are our own.
GlaxoSmithKline (GSK) executives are being accused of burying negative studies on the company's antidepressant drug, Paxil, and its link to birth defects – from consumers and the U.S. Food and Drug Adminstration (FDA). The allegations are likely to have a very damaging effect on the pharmaceutical giant as Paxil litigation begins in the United States.
“If neg, results can bury”
That statement was written by GSK executive Bonnie Rosello in 1997 and referenced what the company should do if it was forced to conduct studies on animals regarding Paxil. Hiding information and failing to warn consumers about the dangers of Paxil are key points in all of the Paxil cases now being litigated.
The first trial, now ongoing in Philadelphia, alleges that GSK knew that Paxil caused birth defects as far back as 1980, but hid those risks from consumers and the FDA to increase sales. Plaintiffs in the first case are the parents of Lyam Kilker, a three year old boy who suffered life threatening heart defects and had to have multiple surgeries because his mother took Paxil during her pregnancy.
Another trial currently ongoing in Boston, involves William Seale, a one year old boy who died in 2004 after his mother took Paxil while she was pregnant. Unfortunately, there are approximately 600 more lawsuits pending which link Paxil to a variety of birth defects and suicides.
Birth defects & suicide
Paxil has been linked to countless birth defects such as cardiac (heart), pulmonary (lung), neural-tube defects (brain and spinal cord), craniosynostosis (abnormally shaped skull), infant omphalocele (abdominal wall defects), club foot (one or both feet turn downward and inward), anal atresia (complete or partial closure of the anus) and suicide or homicidal thoughts. In fact, the company settled a lawsuit with the New York Attorney General's Office for $2.5 million over allegations that GSK suppressed research showing that Paxil may increase the risk of suicide in young people.
If you've been injured by Paxil, contact an experienced drug litigation attorney for a free case review. You may be entitled to compensation for your injuries.